Pastor Ted Says…
Proving again that there's no hypocrisy immune to T-shirt satirization, CafePress.com is selling Ted Haggard garb with aphorisms like the one above. (h/t: Chris from Hollywood Ghetto)
Proving again that there’s no hypocrisy immune to T-shirt satirization, CafePress.com is selling Ted Haggard garb with aphorisms like the one to the right. (h/t: Chris from Hollywood Ghetto)
Rock Solid JournalismIn 2026, amid chaos and the nonstop flurry of headlines, Truthdig remains independent, fact-based and focused on exposing what power tries to hide.
Support Independent Journalism.
Related Stories
Pressed by constituents and state officials, lawmakers of both parties agree to broaden the scope of a $1.5 billion grant program.
With New Hampshire battling record overdose deaths, the sense has emerged that candidates who are not prepared to discuss the matter may as well skip the state's primary.
A huge billboard bearing harsh public service ads like these greet motorists entering Montana. They're part of a massive anti-meth campaign funded by software billionaire Thomas Siebel to combat a drug that's ravaging the country's rural and gay communities (and is making headway elsewhere).
A withered, wasted-away 34-year-old meth addict, who lives on a hospital bed in his father's house, is the subject of a film about his agonies--produced as a warning to would-be speed users.
Pressed by constituents and state officials, lawmakers of both parties agree to broaden the scope of a $1.5 billion grant program.
With New Hampshire battling record overdose deaths, the sense has emerged that candidates who are not prepared to discuss the matter may as well skip the state's primary.
A huge billboard bearing harsh public service ads like these greet motorists entering Montana. They're part of a massive anti-meth campaign funded by software billionaire Thomas Siebel to combat a drug that's ravaging the country's rural and gay communities (and is making headway elsewhere).
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.